Zytiga

Zytiga is the brand name for the drug abiraterone acetate. It is a medication used to treat a specific type of prostate cancer, known as castration-resistant prostate cancer (CRPC). This type of cancer continues to grow even when the body's testosterone levels are lowered through medical or surgical treatments. Zytiga is typically prescribed to men whose prostate cancer has spread to other parts of the body or who have not responded to chemotherapy.

Abiraterone acetate works by inhibiting an enzyme called CYP17A1. This enzyme is involved in the production of androgens, including testosterone, in the body. By blocking this enzyme, Zytiga significantly reduces the levels of androgens in the body, which can slow down the growth of prostate cancer cells, as these cells often rely on androgens to grow.

Zytiga is taken orally, usually once a day. It is generally administered along with a corticosteroid, such as prednisone, to help manage potential side effects. Common side effects can include fatigue, joint pain, hot flashes, and diarrhea. More serious side effects, though less common, can include liver problems, high blood pressure, and heart issues. It is important for patients to discuss the risks and benefits of Zytiga with their healthcare provider. The effectiveness and tolerability of Zytiga can vary from person to person.